Low-quality and fake anti-malarial drugs flooding into markets in Asia and Africa are driving drug resistance and threatening gains made in the fight against the disease in the past decade, according to a study by global health experts.
The study found that about 36 percent of anti-malarial drugs analyzed in Southeast Asia were fake, while a third of samples in sub-Saharan Africa failed chemical testing because they contained either too much or not enough of the active ingredient.
The researchers said the problem might be even bigger.
The emergence of resistance to artemisinin drugs — currently the most effective treatment for malaria — along the Thailand-Cambodia border has already been documented.
“Despite a dramatic rise in reports of poor-quality anti-malarial drugs over the past decade, the issue is much greater than it seems,” Gaurvika Nayyar, of the Fogarty International Center at the US National Institutes of Health, said in a study in the Lancet Infectious Disease journal.
“Most cases are probably unreported, reported to the wrong agencies, or kept confidential by pharmaceutical companies,” Nayyar wrote.
More than 3 billion people worldwide are at risk of malaria, a mosquito-borne parasitic disease that kills about 650,000 people a year, most of them babies and children in Africa.
Nayyar said many of the deaths caused by the disease could be avoided “if drugs available to patients were efficacious, high quality, and used correctly.”
The WHO estimates that while less than 1 percent of medicines available in developed countries are likely to be counterfeit, the figure is about 10 percent globally.
The UN agency estimates that as much as a third of all medicines in some developing countries is fake.
As well as putting patients at risk, counterfeit drugs are a constant bane for companies like GlaxoSmithkline, Sanofi and other international drugmakers.
Nayyar’s team analyzed data from both published and unpublished studies that looked at chemical analyses and the packaging of malaria medicines in sub-Saharan Africa and Southeast Asia, where the malaria risk is highest.
Data from seven countries in Southeast Asia — including from analysis of 1,437 samples of seven different malaria drugs — showed that more than a third of them failed chemical testing, nearly half were wrongly packaged and about a third were bogus.
Analysis of data from 21 countries in sub-Saharan Africa that included more than 2,500 drug samples showed similar results, with more than a third failing chemical testing and about one-fifth turning out to be fake.
The pitch is a classic: A young celebrity with no climbing experience spends a year in hard training and scales Mount Everest, succeeding against some — if not all — odds. French YouTuber Ines Benazzouz, known as Inoxtag, brought the story to life with a two-hour-plus documentary about his year preparing for the ultimate challenge. The film, titled Kaizen, proved a smash hit on its release last weekend. Young fans queued around the block to get into a preview screening in Paris, with Inoxtag’s management on Monday saying the film had smashed the box office record for a special cinema
CRITICISM: ‘One has to choose the lesser of two evils,’ Pope Francis said, as he criticized Trump’s anti-immigrant policies and Harris’ pro-choice position Pope Francis on Friday accused both former US president Donald Trump and US Vice President Kamala Harris of being “against life” as he returned to Rome from a 12-day tour of the Asia-Pacific region. The 87-year-old pontiff’s comments on the US presidential hopefuls came as he defied health concerns to connect with believers from the jungle of Papua New Guinea to the skyscrapers of Singapore. It was Francis’ longest trip in duration and distance since becoming head of the world’s nearly 1.4 billion Roman Catholics more than 11 years ago. Despite the marathon visit, he held a long and spirited
‘DISAPPEARED COMPLETELY’: The melting of thousands of glaciers is a major threat to people in the landlocked region that already suffers from a water shortage Near a wooden hut high up in the Kyrgyz mountains, scientist Gulbara Omorova walked to a pile of gray rocks, reminiscing how the same spot was a glacier just a few years ago. At an altitude of 4,000m, the 35-year-old researcher is surrounded by the giant peaks of the towering Tian Shan range that also stretches into China, Kazakhstan and Uzbekistan. The area is home to thousands of glaciers that are melting at an alarming rate in Central Asia, already hard-hit by climate change. A glaciologist, Omarova is recording that process — worried about the future. She hiked six hours to get to
The number of people in Japan aged 100 or older has hit a record high of more than 95,000, almost 90 percent of whom are women, government data showed yesterday. The figures further highlight the slow-burning demographic crisis gripping the world’s fourth-biggest economy as its population ages and shrinks. As of Sept. 1, Japan had 95,119 centenarians, up 2,980 year-on-year, with 83,958 of them women and 11,161 men, the Japanese Ministry of Health said in a statement. On Sunday, separate government data showed that the number of over-65s has hit a record high of 36.25 million, accounting for 29.3 percent of